Dubnica nad Váhom
Dubnica nad Váhom
Dubnica nad Váhom, Slovakia7 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3) | Psychosis Associated With Alzheimer's Disease | Recruiting | Phase 3 | 2026-09-29 | NCT05980949 | |
| A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine | Chronic Migraine | Recruiting | Phase 3 | 2026-09-25 | NCT07018713 | |
| A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine | Episodic Migraine | Recruiting | Phase 3 | 2026-09-25 | NCT07018700 | |
| A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4) | Alzheimer disease, Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 3 | 2026-09-22 | NCT06585787 | |
| A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy | Epilepsy, Absence, Epilepsy, Generalized, Epileptic Syndromes, brain disorder, central nervous system disorder, childhood absence epilepsy, epilepsy, juvenile absence epilepsy, nervous system disorder | Active, not recruiting | Phase 3 | 2026-08-27 | NCT06315322 | |
| A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1) | Psychosis Associated With Alzheimer's Disease | Recruiting | Phase 3 | 2026-08-17 | NCT05511363 | |
| A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine | brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorder | Active, not recruiting | Phase 3 | 2026-07-30 | NCT06616194 |